Press release
Global Chronic Kidney Disease (CKD) Market (Covid 19 Update) Competitive Insights, Trends and Demand Growth 2020 to 2027
Global Chronic Kidney Disease (CKD) Market
Global Chronic Kidney Disease (CKD) Market is expected to rise gradually to an estimated value of USD 19.02 billion by 2026, registering a CAGR of 4.5% in the forecast period of 2019-2026 with the annual sales of USD 13.38 billion in the year 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.
Few of the major competitors currently working in the Global chronic kidney diseases market are Pfizer Inc. (US), Amgen, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (US), Bristol-Myers Squibb Company (US), GlaxoSmithKline Plc (UK), Novartis AG (Switzerland), Sanofi S.A (France), Teva Pharmaceutical Industries Ltd (Israel), Fresenius SE & Co. KGaA ( Germany), Kissei Pharmaceutical Co., Ltd ( Japan), AbbVie Inc (US), Allergan Plc ( Ireland) and few among others.
Request for FREE sample copy or PDF Here @ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-chronic-kidney-disease-ckd-market&Pm
A grouping of market intelligence and industry expertise employed in this Chronic Kidney Disease (Ckd) Market report surely helps achieve the business goals. The report is prepared by taking into account the client’s requirements with respect to the market type, size of the organization, accessibility on-premises and the end-users’ organization type, and availability at global level in areas such as North America, South America, Europe, Asia-Pacific, Middle East and Africa. The Chronic Kidney Disease (Ckd) Market report has been generated by strictly following commitments and deadlines to deliver the finest market report. The report proves to be very encouraging for both established business and emerging market player in the industry as it contains profound market insights.
Market Definition: Global Chronic Kidney Disease (CKD) Market
Chronic Kidney disease (CKD) is a serious condition identified by progressively loss of kidney function over a time. CKD is not only treatable but also a major contributing factor for death. CKD can be classified into five stages from mild stage 1 to complete kidney damage in stage 5.
According to the WHO, Global Burden of Disease (GBD) 2015, it is estimated that more than 7.00 million patient with chronic kidney disease died without approaching any medication. This data shows lack of awareness and poor availability of intervention.
Chronic Kidney Disease (CKD) Market Drivers
Increase in prevalence rate of hypertension, diabetes and cardiovascular diseases.
Rising awareness about transplantation therapy and technological advancement is driving the growth of market.
Increase in the rate of R&D initiatives is driving chronic kidney disease therapeutics market.
Chronic Kidney Disease (CKD) Market Restraints
High cost involved in the treatment.
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market.
Segmentation: Global Chronic Kidney Disease (CKD) Market
Chronic Kidney Disease (CKD) Market : By Therapy Type
Medication
Kidney Transplantation
Dialysis
Others
Chronic Kidney Disease (CKD) Market : By route of administration
Oral
Chronic Kidney Disease (CKD) Market : By End users
Hospitals
Homecare
Specialty Clinics
Others
Chronic Kidney Disease (CKD) Market : By Geography
North America
South America
Europe
Asia-Pacific
Middle East & Africa
Browse Detailed TOC here @ https://www.databridgemarketresearch.com/toc?dbmr=global-chronic-kidney-disease-ckd-market&PM
Key Developments in the Chronic Kidney Disease (CKD) Market:
On April 2019, FDA approved Keytruda a drug manufactured by Merck & Co., Inc. for the treatment of advanced renal cell carcinoma in the therapy area of nephrology and oncology. The drug acted as immunomodulatory. It is specifically given in the combination of axitinib which is first line treatment of patient diagnosed with renal cell carcinoma.
On April 2018, Otsuka Pharmaceuticals Co., Ltd got FDA approval for Jynarque in the therapy area of nephrology for the treatment of autosomal dominant polycystic kidney disease. The drug is given in tablet form and it act as a selective vasopressin V2-receptor antagonist.
Reasons to Purchase this Report
Current and future of Global chronic kidney diseases market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Want Full Report? Enquire Here @ https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-chronic-kidney-disease-ckd-market&pm
Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Chronic Kidney Disease (CKD) Market (Covid 19 Update) Competitive Insights, Trends and Demand Growth 2020 to 2027 here
News-ID: 2069540 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Kidney
Wearable Artificial Kidney Market Development Trajectory through 2031 Dutch Kidn …
"[New York, December 2024] The Wearable Artificial Kidney represents a groundbreaking innovation in nephrology that combines advanced biomedical engineering with portable technology. Designed to continuously filter waste from the blood, this device caters primarily to patients with chronic kidney disease. As renal health issues become more prevalent globally, the relevance of the Wearable Artificial Kidney lies in its potential to enhance patient quality of life, providing a more convenient and…
Kidney Dialysis Market Share Kidney Dialysis Market
According to Ameco Research 'Kidney Dialysis Market report, the analysts took this into account when estimating the Kidney Dialysis Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Kidney Dialysis Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Kidney Dialysis Market trends, segmentation, key…
Kidney Health Journey: Polycystic Kidney Disease Drug Pipeline Landscape (2023-2 …
Market Outlook:
The Polycystic Kidney Disease (PKD) drug pipeline landscape is poised for noteworthy advancements, offering a positive outlook for those navigating the complex journey of kidney health. As PKD poses a significant global health burden, the market outlook reflects a pressing need for innovative pharmaceutical interventions to address the challenges associated with this genetic disorder. With ongoing research and development efforts, the PKD drug pipeline is positioned to bring…
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview:
Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029.
The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.…
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025
Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
